Obesity is a prevalent comorbidity of pulmonary arterial hypertension (PAH), according to a recent study that…
Articles by Maureen Newman
In a world where vasodilators rule the landscape of treatments for pulmonary arterial hypertension (PAH), scientific research groups and pharmaceutical…
Non-invasive techniques to detect pulmonary hypertension in individuals who are at a high risk for developing the disease are in…
Research scientists at Bayer HealthCare AG in Germany are optimizing a new chemical inhibitor for pulmonary arterial hypertension (PAH) treatment.
The recent announcement of positive results for the AMBITION trial testing combinatorial ambrisentan and tadalafil in patients…
A variety of biomarkers are elevated in the serum of patients with systemic sclerosis-pulmonary arterial hypertension (SSc-PAH). Researchers have mostly…
Connective tissue diseases that largely affect bone, cartilage, and fat can sometimes be associated with pulmonary hypertension. Since not all…
A new study from University Medical Center Gronigen in The Netherlands, released on fast-track by the…
The amino acid arginine may contribute to pulmonary hypertension in patients with thalassemia, a disorder that leads to abnormal oxygenation…
Patients with pulmonary hypertension may be surprised to know that the disease can sometimes be accompanied by the complication known…
Uric acid is most often associated with gout in patients. However, a new study published in…
The inflammasome, which is a multi-protein complex that activates inflammatory processes, was shown to play a role in pulmonary hypertension according…